Back to CVE records
Critical 9.3Published Oct 23, 2026

CVE-2026-55486Goobi viewer: IIIF Auth 2.0 origin parameter unsanitized — CSP malformation and reflected XSS

Updated under an hour ago ()

Does this affect you?

It affects intranda goobi-viewer-core. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.46%, higher than 39% of scored CVEs.

The Goobi viewer is a web application that allows digitised material to be displayed in a web browser. From version 25.08 to before version 26.05, the IIIF Auth 2.0 endpoints auth/login and auth/token in AuthorizationFlowResource accept an origin query parameter without validation and then (1) embed it into the Content-Security-Policy: frame-ancestors response header and (2) embed it into an HTML response body as a JavaScript single-quoted postMessage argument. Because the attacker controls both the login and token calls that initiate the flow, the unescaped value yields reflected XSS. This issue has been patched in version 26.05.

CVSS
9.3 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
Weakness (CWE)
CWE-79, CWE-113, CWE-1336
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.46% (percentile 39)
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Oct 23, 2026
First seen by InfoSec Signals
Oct 23, 2026

Affected products

Affected products
intranda goobi-viewer-core
intranda:goobi_viewer_core (from the name)
from 25.08, < 26.05
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.